| | | | | | | |
 | GILEAD SCIENCES, INC. | -0.28% | 2.36% | -12.33% | -5.59% | -4.83% | 80 075 |
| REGENERON PHARMACEUTICALS, INC. | 3.14% | 2.42% | 7.98% | 36.25% | 118.17% | 71 235 |
| VERTEX PHARMACEUTICALS | 3.77% | 4.81% | 22.20% | 27.05% | 56.23% | 66 136 |
 | WUXI APPTEC CO., LTD. | -1.03% | -1.87% | -17.77% | -28.39% | 189.98% | 42 735 |
| BIONTECH SE | 0.13% | 2.62% | -36.69% | -16.25% | --.--% | 39 612 |
 | GENMAB A/S | -0.92% | 7.03% | -18.02% | -11.39% | 76.22% | 20 205 |
 | ARGENX SE | -0.98% | 2.45% | -4.12% | 36.97% | 149.22% | 17 597 |
| BEIGENE, LTD. | -1.57% | 3.35% | -50.11% | -60.59% | 6.76% | 14 168 |
| NEUROCRINE BIOSCIENCES, INC. | 0.36% | 2.45% | 1.55% | -9.73% | 8.26% | 8 237 |
| LEGEND BIOTECH CORPORATION | -6.24% | 8.26% | -14.29% | 3.10% | --.--% | 6 572 |
| SAREPTA THERAPEUTICS, INC. | 0.67% | 7.82% | -20.48% | -7.25% | -40.74% | 6 224 |
| HALOZYME THERAPEUTICS, INC. | 0.02% | 9.65% | 10.25% | 5.70% | 187.67% | 6 106 |
| EXELIXIS, INC. | -0.06% | -11.55% | -2.90% | -25.04% | -12.82% | 5 696 |
| INTRA-CELLULAR THERAPIES, INC. | 0.92% | -2.06% | 11.60% | 52.59% | 333.63% | 5 459 |
| ASCENDIS PHARMA A/S | 1.69% | 14.77% | -27.89% | -28.19% | -24.78% | 5 324 |
| | | | | | | |
| | Gemiddelde | -0.03% | 3.50% | -10.07% | -2.05% | 80.23% | |
| | Gewogen gemiddelde per kap. | 0.84% | 2.83% | -6.47% | 3.93% | 76.48% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
